Eric H. Bernicker, MD

Diane Harkins Modesett Clinical Academic Scholar, Houston Methodist
Associate Professor of Clinical Medicine in Oncology, Academic Institute
Associate Clinical Member, Research Institute
Cancer Center
Department of Medicine
Houston Methodist Hospital
Weill Cornell Medical College

639 Citations
10 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Dr. Bernicker earned his medical degree from Baylor College of Medicine in Houston, TX in 1990. Subsequently, he completed his residency at Baylor Affiliated Hospitals and was chief medical resident at Ben Taub General Hospital from 1993–1994. Dr. Bernicker held a faculty appointment at Baylor College of Medicine as a clinical assistant professor from 1996–2012 before joining the Houston Methodist Cancer Center in January 2013, where he serves as director of Medical Thoracic Oncology. As a physician-scientist, Dr. Bernicker oversees the expansion of clinical trials at The Methodist Hospital relating to Thoracic Oncology with all stages of disease, a combination of SWOG trials, and industry trials of novel targeted agents.

Research interests

Dr. Bernicker’s research focuses on looking at different therapeutic approaches, such as targeted therapies and immunotherapies, in the treatment of lung cancer. By understanding how to identify patients at risk for relapse after surgery or those who can be spared the toxicities of chemotherapy, the immune system can be stimulated to preferentially destroy tumor cells, spare normal tissues, and improve patient survival along with the development of less toxic therapeutics. Eventually, the goal is to be able to offer new therapies and clinical trials to patients at Methodist with any stage of non-small cell lung cancer or small cell lung cancer.

Education/Academic qualification

Medical Oncology, Clinical Fellowship, Baylor College of Medicine

Jul 1 1994 → Sep 30 1996

Award Date: Sep 30 1996

MD, Baylor College of Medicine

May 1 1990 → Jun 1 1994

Award Date: Jun 1 1994

Internal Medicine, Residency, Baylor College of Medicine

Jan 1 1991 → Jun 30 1993

Award Date: Jun 30 1993

Internship, Dallas County Hospital -Parkland Memorial Hospital

Jan 1 1990 → Jan 1 1991

Award Date: Jan 1 1991

Research Area Keywords

Cancer
Clinical Translation & Trials
Clinical Care

Free-text keywords

Cancer research
Lung cancer
Targeted therapeutics

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

8 Not started
51 Active

Phase III_MRx0518Pembrolizumab_Solid Tumors_4D Pharma MRx0518-I-002

Bernicker, E. H., Darcourt, J. & Zhang, J.

9/25/20 → …

Project: Clinical Trial

A Phase 2, Multicenter, Single-arm Study of Retreatment With Brentuximab Vedotin in Subjects With Relapsed or Refractory Classic Hodgkin Lymphoma (cHL) or CD30-expressing Peripheral T Cell Lymphoma (PTCL)

Pingali, S. R., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Niravath, P. A., Petkova, J., Randhawa, J., Rice, L. & Singh, M.

7/8/20 → …

Project: Clinical Trial

A Phase 2, Multicenter, Open-label, Safety and Efficacy Study of XERMELO® (Telotristat Ethyl) Plus First-line Chemotherapy in Patients With Locally Advanced, Unresectable, Recurrent or Metastatic Biliary Tract Cancer (BTC)

Abdelrahim, M., Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.

4/27/20 → …

Project: Clinical Trial

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Randhawa, J., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.

4/17/20 → …

Project: Clinical Trial

A Randomized, Open-label, Phase II Study of Canakinumab or Pembrolizumab as Monotherapy or in Combination as Neoadjuvant Therapy in Subjects With Resectable Non-small Cell Lung Cancer (CANOPY-N)

Bernicker, E. H., Barrios, R., Chan, E. Y., Chang, J. C., Darcourt, J., Heyne, K., Kim, M. P., Niravath, P. A., Singh, M. & Zhang, J.

4/9/20 → …

Project: Clinical Trial